Abstract. Hepatoid adenocarcinoma (HAC) is a rare form of gastric cancer that has unique clinicopathological features and an extremely poor prognosis. The present case report describes a patient who was referred to the No. 461 Hospital of PLA (Changchun, China) due to nausea and occasional vomiting of acid/water. The patient was diagnosed with gastric signet-ring cell carcinoma and surgery was recommended. A total gastrectomy was performed on the operable lesion. Histopathological analysis revealed that the tumors exhibited two pathological changes: HAC and signet-ring cell carcinoma differentiation. Furthermore, the tumor cells were immunohistochemically positive for α-fetoprotein, cytokeratin low/high molecular weight, Cam5.2, cytokeratin 7, p53, epithelial membrane antigen and carcinoembryonic antigen. Previous studies and our experience have suggested that HAC is an aggressive type of adenocarcinoma; however, radical surgery and chemotherapy may positively impact clinical outcomes.
Introduction
Hepatoid adenocarcinoma (HAC) is a type of gastric cancer with adenoid and hepatocyte differentiation. In 1985, Ishikura et al (1) first presented and stated that HAC was a cancer with hepatocyte characteristics: hepatoid adenocarcinoma of the stomach (HAS). The levels of extrahepatic α-fetoprotein (AFP) in the serum and tumor tissue are high in this form of gastric cancer, similarly to hepatocellular carcinoma (HCC). Since the study by Ishikura et al, there have been subsequent studies published on the clinical manifestation and pathological features of HAC (2) (3) (4) . This tumor type has poor prognosis and therefore accurate diagnosis of HAC is extremely important. The first description of HAC was in the stomach, which remains the most common tumor location; however, HAC has been reported to develop in a variety of organs including the gallbladder, lungs, bladder, esophagus, pancreas, peritoneum, jejunum, colon, rectum, renal pelvis, ureter, ovaries, uterus and papilla of Vater (5) (6) (7) (8) . HAS is a relatively rare gastric carcinoma and has an extremely poor diagnosis. Only a few cases have been previously reported. The present case report describes a patient who experienced acid regurgitation, belching, nausea and occasional vomiting of acid/water, which was more notable on an empty stomach. No diarrhea or abdominal distension was observed but the patient's stools were black.
Case report
A 47-year-old male presented with repetitive upper abdominal ache, without obvious inducement, that had lasted three and a half months. The ache was accompanied with acid regurgitation and belching, which was more notable on an empty stomach. The patient had nausea and occasional acid vomiting but no diarrhea or abdominal distension. The patient's stools were black. Following gastroscopy and pathological examination, the patient was diagnosed with gastric signet-ring cell carcinoma and a total gastrectomy was performed on the operable lesion. Abdominal ultrasonography showed normal results in the liver, gallbladder, pancreas, spleen and kidney, and CEA levels were normal. The patient did not have lymph node metastasis or other organ metastasis. Thus, 2 weeks following surgery the patient left hospital without undergoing chemotherapy or radical therapy. He is currently being followed up for 12 months. Informed consent was obtained from the patient and the patient's family prior to participation in the present study.
Pathological examination Naked eye. The whole stomach was inspected: The greater gastric curvature measured 26 cm and the lesser gastric curvature measured 14 cm. A 2.3 x 2.2 x 2.0-cm nodule was
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A case report and literature review identified on the serosal surface. On incision along the greater curvature side, a 4.5 x 3.5 x 0.4 cm ulcerative neoplasm was found 4.5 cm from the pylorus and 6.0 cm from the gastric cardia, on the lesser gastric curvature side (Fig. 1) . Following incision along the ulcerative neoplasm, it was observed that the section was brown and gray, hard and had invaded the shallow muscularis. An isolated circular nodule, which was 2.0 cm in diameter, gray and hard, with clear boundaries (Fig. 2) . Microscopic evaluation. The mucosa of the neoplasm showed features consistent with signet-ring cell carcinoma (Fig. 3) ; however, large cells arranged in a solid, clumped shape were observed on the serosa of the neoplasm. The nuclei were large and centrally located. Nucleolus and nuclear fission were observed. The cytoplasm was abundant, acidophilic and transparent. A small amount of fibrous tissue, capillaries and a Periodic-Acid Schiff (PAS)-positive corpuscle with necrosis were also observed (Fig. 4) .
Immunohistochemistry (IHC).
Positive results for cytokeratin low/high molecular weight (AE1/AE3), Cam5.2, cytokeratin 7, p53, epithelial membrane antigen (EMA) and carcinoembryonic antigen (CEA) were found on both sides of the neoplasm. Staining for AFP was strongly positive in the neoplasm at the serosa (Fig. 5) . Tests for neuroendocrine markers (synaptophysin, chromogranin A and cluster of differentiation 56), mesothelioma markers (calretinin, D240 and mesothelial cells), markers of the gastric choriocarcinoma (β-human chorionic gonadotrophin and inhibin) and a marker of squamous cell carcinoma (p63) were negative.
Pathological diagnosis. The patient was diagnosed with gastric adenocarcinoma combined with HAC and signet-ring cell carcinoma differentiation. The signet-ring cell carcinoma invaded the middle muscularis. Three out of the 19 lymph nodes on the greater gastric curvature were identified as metastases and one of the 10 lymph nodes on the lesser gastric curvature was a metastasis. All metastases were signet-ring cell carcinoma.
Discussion
HAC is a type of gastric cancer with adenoid and hepatocyte differentiation. In 1985, Ishikura et al (1) first presented and stated unequivocally that HAC was a cancer with hepatocyte characteristics. Levels of AFP in the serum and tumor tissue are significantly high in this form of gastric cancer; however, HAC is rare, accounting for 1.3-15% of gastric cancers (9) . Although there have been some previous reports about this disease (10, 11) , there remains a lack of understanding. HAC is discussed here with reference to the present case and published literature.
HAC, an aggressive and highly malignant tumor, is a type of adenocarcinoma with the structural and cytological characteristics of HCC that occurs in extrahepatic organs or tissues. In cases of HAC, high levels of AFP can be detected in the serum and tumor tissue. HAC usually occurs in the stomach; however, the tumors may also be observed in the duodenum, colon, rectum, esophagus, gallbladder, pancreas, lung, bladder, kidney, ureter, ovaries, uterus, retroperitoneum and local soft tissue (12) . HAS occurs more frequently than the other types of HAC, generally occurs in middle-aged patients and is more commonly found in males than females. It is likely that it originates in the gastric antrum and is associated with infiltration and ulceration. The tumor locates itself in the submucosa and infiltrates to the muscularis layer. HAS generally has no specific clinical symptoms, and the digestive tract symptoms, such as abdominal pain, abdominal distension and black stools, are often apparent in the middle and late periods of the disease. HAC is frequently associated with an elevated serum AFP and positive staining for AFP in IHC tests. Postoperative serum AFP levels may be used as a predictive index for tumor recurrence or metastasis (13). HAC is additionally prone to spread to the liver and lymph nodes, since it is similar to liver cancer cells in histology. A thrombus is easily formed and can invade the vascular system early on due to a rich blood supply. In certain studies, the blood and lymphatic vessel invasion by HAS and the level of surrounding lymph node metastasis have been observed to be evidently higher than those associated with a less-differentiated gastric adenocarcinoma (14, 15) ; however, in the present case, the lymph node metastasis was signet-ring cell carcinoma rather than HAC, which was not in conformity with the literature.
Pathologically, HAC comprises primary tumors in the gastric mucosa gland. The tumor cells generally form two different but closely associated areas: Adenocarcinoma and hepatocellular cancer. The former is a poorly differentiated, visible tubular and papillary adenocarcinoma (5,16) . The latter exhibits HCC differentiation. The pathology and IHC of HAC show numerous features. Under a microscope, the cancer cells are large with abundant cytoplasm, and the nuclei are round or ovoid. The nucleolus and mitotic spindle can be observed and the cytoplasm exhibits pale eosin staining (17) . A small number of cancer cells (transparent and acidophilic polygonal cells) form the medullary or cable structure. These cells are separated by a few fibrous tissues and a rich blood supply, and exhibit transitional or overlapping processes. Visible eosinophilic hyaline PAS-positive corpuscles lie between the cells. The cancer cells may show different degrees of liver cell differentiation, characterized by fatty degeneration or the secretion of bile. Under the electron microscope, a capillary bile duct structure may be observed between tumor cells. The two areas of HAC both exhibit intestinal epithelial microvilli, which come from the gastrointestinal epithelium. In IHC, tests for AFP are strongly positive or positive, tests for CEA may be positive or negative and tests for α1-antitrypsin and α1-antichymotrypsin are positive in the liver cancer region. AFP expression is strongly positive on the serosal surface. According to the results of AFP IHC staining, HAC can be divided into AFP-positive and AFP-negative types (18); however based on the characteristics of structural organization, HAC can be divided into simple (only the structure of liver cancer) and mixed (adenocarcinoma and HCC) types. In the current case, the HAC was an AFP-positive, mixed type.
It is important to monitor the increase in serum AFP level and the expression of AFP in tumor tissues when studying HAC. Patients with HAC have higher serum AFP levels. It is generally believed that this may be due the following factors: i) The liver-differentiated area of the HAC produces AFP; ii) the gastric cancer itself produces AFP instead of the liver-differentiated area; iii) the gastric cancer metastasizes to the liver and AFP is then produced by the new or proliferating hepatocytes (19) . Inagawa et al (2) reported that the serum AFP level was associated with the differentiation degree, and Chang et al (20) found that a higher serum AFP level resulted in a poorer prognosis than that for AFP-negative gastric cancer. Nagai et al (21) suggested that patients with HAC with a high or normal AFP had the same prognosis.
Gastric cancer is complex and highly heterogeneous. There have been few studies regarding the differences between the signet-ring cell carcinoma and HAC. Akiyama et al (22) found that tubular adenocarcinoma and HAC had the same origin following the technical application of molecular pathology. Both carcinomas had X chromosome and p53 loss; therefore we hypothesize that they have the same origin. Tumors from the same origin can have different biological behavior, morphology and IHC profiles, which fully reflect the heterogeneous characteristics of tumor growth. This feature makes the treatment of such tumors difficult, due to their particularly complex biological behavior and poor prognosis.
In summary, the present study described an unusual case of HAC which had a morphological similarity to HCC. On initial observation, the elevation in the level of AFP was caused by HCC; however, the second spike in the level of AFP was due to HAC. Thus, a differential diagnosis of HAC should be considered in cases involving the elevation of the levels of serum AFP, even in patients at a high risk of HCC.
